Literature DB >> 20674008

Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.

Jillian E Tengood1, Kyle M Kovach, Patrick E Vescovi, Alan J Russell, Steven R Little.   

Abstract

Angiogenesis is an organized series of events, beginning with vessel destabilization, followed by endothelial cell re-organization, and ending with vessel maturation. Vascular endothelial growth factor (VEGF) aids in vascular permeability and endothelial cell recruitment while sphingosine 1-phosphate (S1P) stimulates vascular stability. Accordingly, VEGF may inhibit vessel stabilization while S1P may inhibit endothelial cell recruitment. For this reason, we created a new externally-regulated delivery model that not only permits sustained release of bioactive factors, but also temporal separation of the delivery of growth factors. Using this model, sequential delivery of factors was first confirmed in vitro with associated endothelial cells responding in a dose dependent manner. Furthermore, using a modified murine Matrigel plug model, it is apparent that delivery strategies where VEGF presentation is temporally separated from S1P presentation not only led to greater recruitment of endothelial cells, but also higher maturation index of associated vessels. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674008      PMCID: PMC2924947          DOI: 10.1016/j.biomaterials.2010.07.010

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  51 in total

Review 1.  Vascular-specific growth factors and blood vessel formation.

Authors:  G D Yancopoulos; S Davis; N W Gale; J S Rudge; S J Wiegand; J Holash
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

2.  Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.

Authors:  H Okamoto; N Takuwa; T Yokomizo; N Sugimoto; S Sakurada; H Shigematsu; Y Takuwa
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect.

Authors:  R C Hendel; T D Henry; K Rocha-Singh; J M Isner; D J Kereiakes; F J Giordano; M Simons; R O Bonow
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

4.  Polymeric system for dual growth factor delivery.

Authors:  T P Richardson; M C Peters; A B Ennett; D J Mooney
Journal:  Nat Biotechnol       Date:  2001-11       Impact factor: 54.908

Review 5.  Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

Authors:  M Simons; R O Bonow; N A Chronos; D J Cohen; F J Giordano; H K Hammond; R J Laham; W Li; M Pike; F W Sellke; T J Stegmann; J E Udelson; T K Rosengart
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

6.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

7.  Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor.

Authors:  Francesco De Marchis; Domenico Ribatti; Claudia Giampietri; Alessandro Lentini; Debora Faraone; Marco Scoccianti; Maurizio C Capogrossi; Antonio Facchiano
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

8.  The sponge/Matrigel angiogenesis assay.

Authors:  Nasim Akhtar; Erin B Dickerson; Robert Auerbach
Journal:  Angiogenesis       Date:  2002       Impact factor: 9.596

Review 9.  Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness.

Authors:  Hiroyuki Nakajima; Yutaka Sakakibara; Keiichi Tambara; Atsushi Iwakura; Kazuhiko Doi; Akira Marui; Koji Ueyama; Tadashi Ikeda; Yasuhiko Tabata; Masashi Komeda
Journal:  J Artif Organs       Date:  2004       Impact factor: 1.731

10.  Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis.

Authors:  M Hellström; H Gerhardt; M Kalén; X Li; U Eriksson; H Wolburg; C Betsholtz
Journal:  J Cell Biol       Date:  2001-04-30       Impact factor: 10.539

View more
  30 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  Exogenous thrombin delivery promotes collateral capillary arterialization and tissue reperfusion in the murine spinotrapezius muscle ischemia model.

Authors:  Anthony C Bruce; Shayn M Peirce
Journal:  Microcirculation       Date:  2012-02       Impact factor: 2.628

3.  Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.

Authors:  Hassan K Awada; Noah R Johnson; Yadong Wang
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

Review 4.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

Review 5.  Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.

Authors:  Bernard Y K Binder; Priscilla A Williams; Eduardo A Silva; J Kent Leach
Journal:  Tissue Eng Part B Rev       Date:  2015-07-14       Impact factor: 6.389

6.  Amphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate.

Authors:  Jing Zhang; Jie Song
Journal:  Acta Biomater       Date:  2014-03-12       Impact factor: 8.947

Review 7.  Clinical translation of controlled protein delivery systems for tissue engineering.

Authors:  Kara L Spiller; Gordana Vunjak-Novakovic
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

8.  Bioerodible system for sequential release of multiple drugs.

Authors:  Sharath C Sundararaj; Mark V Thomas; Thomas D Dziubla; David A Puleo
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

9.  Ordered and kinetically discrete sequential protein release from biodegradable thin films.

Authors:  Bryan B Hsu; Kelsey S Jamieson; Samantha R Hagerman; Eggehard Holler; Julia Y Ljubimova; Paula T Hammond
Journal:  Angew Chem Int Ed Engl       Date:  2014-06-18       Impact factor: 15.336

Review 10.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.